StockData

Heartflow vs Shoulder Innovations

HTFL and SI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How HTFL and SI compare

Heartflow is the larger company, worth 11 times as much as Shoulder Innovations ($5.1B against $456M).

Shoulder Innovations grew revenue faster over the last twelve months (54.9% versus 42.8% for Heartflow).

Shoulder Innovations keeps more of each dollar of sales as profit, with a net margin of −51.7% compared with −55.8% at Heartflow.

Shoulder Innovations scores higher on the StockData Score (8 against 5 for Heartflow), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricHTFLSI
Size and price
Market cap$5.1B$456M
Share price$59.10$21.92
Change, 1 year74.7%99.1%
Beta (5Y)1.96–
Employees84375
StockData Score
Total score58 (better)
Valuation score00
Growth score33
Performance score01 (better)
Health score24 (better)
Dividend score00
Valuation
P/S24.2×7.1× (better)
P/B18.4×3.9× (better)
FCF yield−1.2% (better)−9.4%
Fair value$8.61$13.51
Margin of safety−586%−62.2% (better)
Growth
Revenue growth (TTM)42.8%54.9% (better)
Profitability
Gross margin80.1% (better)77.8%
Operating margin−37.8% (better)−54.4%
Net margin−55.8%−51.7% (better)
FCF margin−27.9% (better)−66.2%
Return on equity–−25.1%
Return on invested capital–−83.6%
Financial health
Debt / equity–0.13
Interest coverage−23.2×–
Current ratio5.0810.68 (better)
Altman Z-score43.51 (better)9.53
Piotroski F-score6 (better)4
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions86.0%39.8%
Held by insiders58.7%40.0%
Insider net buying, 12 months−$143M−$5.3M (better)
Short interest, % of float15.9%5.7%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.